WK Cancer Treatement Center

Clinical Trials

Anemia with Advanced Stage Non-small Cell Lung Cancer Receiving Multi-Cycle Chemotherapy


To demonstrate the overall survival of subjects receiving a single agent for Chemo-Induced Anemia in Stage IV Non-small Cell Lung Cancer patients.


  • Male and Female patients at least 18 years of age 
  • Confirmed diagnosis of Stage IV Non-small Cell Lung Cancer (not recurrent or re-staged) 
  • Expected to receive at least 2 additional cycles of first line myelosuppressive cyclic chemotherapy 
  • Requiring a baseline radiographic scan of the chest to assess disease burden before starting on first line chemotherapy  


  • Screening Period: up to 21 days 
  • Treatment Period: at least 6 total weeks 
  • Study visits: every 3 weeks 
  • Radiographic imaging: every 9 weeks  

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at (318) 212-8671.